Fresenius SE reduces its holding in Fresenius Medical Care to roughly 20%
Fresenius SE lowered its ownership of Fresenius Medical Care from 25% to about 20% by selling a block of shares. The transaction involved 13.4 million shares at €39 each, generating €524 million in cash. The remaining shares are subject to a 90‑day lock‑up period. The parent company said the proceeds will lift its book profit by several tens of millions of euros in Q4 2026.
Why it matters
The cash from the sale is expected to raise Fresenius SE's book profit by a low‑to‑mid double‑digit million‑euro amount in the fourth quarter, which could improve its earnings outlook. The reduction in stake may also influence Fresenius Medical Care’s share dynamics as investors react to the parent’s divestiture.
Key facts
- 1Fresenius SE cut its stake in Fresenius Medical Care from 25% to about 20%. seekingalpha.com
- 2The company sold 13.4 million Fresenius Medical Care shares for €524 million. econotimes.com
- 3The sale price was €39 per share. econotimes.com
- 4Proceeds are projected to increase book profit by a low‑to‑mid double‑digit million‑euro amount in Q4 2026. econotimes.com
- 5The shares that remain after the sale are under a 90‑day lock‑up. econotimes.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.